Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP498783.RA3AM_NXO9YjQ9EGAjxZsg3NDP_NQOc3aYXLTEvyqv3P0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP498783.RA3AM_NXO9YjQ9EGAjxZsg3NDP_NQOc3aYXLTEvyqv3P0130_assertion type Assertion NP498783.RA3AM_NXO9YjQ9EGAjxZsg3NDP_NQOc3aYXLTEvyqv3P0130_head.
- NP498783.RA3AM_NXO9YjQ9EGAjxZsg3NDP_NQOc3aYXLTEvyqv3P0130_assertion description "[Establishment of coronavirus NS2-specific, HLA-A2-restricted CD8(+)-T-cell clones and ex vivo analysis of HPV16 E7 specific T cells obtained by HLA-A2 tetramer-guided sorting from PBL or tumor-infiltrating lymphocytes obtained from patients with cervical cancer showed that cross-reactivity with HPV16 E7(11-19(20)) and coronavirus NS2(52-60) represents a common feature of this antiviral immune response defined by cytokine production.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498783.RA3AM_NXO9YjQ9EGAjxZsg3NDP_NQOc3aYXLTEvyqv3P0130_provenance.
- NP498783.RA3AM_NXO9YjQ9EGAjxZsg3NDP_NQOc3aYXLTEvyqv3P0130_assertion evidence source_evidence_literature NP498783.RA3AM_NXO9YjQ9EGAjxZsg3NDP_NQOc3aYXLTEvyqv3P0130_provenance.
- NP498783.RA3AM_NXO9YjQ9EGAjxZsg3NDP_NQOc3aYXLTEvyqv3P0130_assertion SIO_000772 12692247 NP498783.RA3AM_NXO9YjQ9EGAjxZsg3NDP_NQOc3aYXLTEvyqv3P0130_provenance.
- NP498783.RA3AM_NXO9YjQ9EGAjxZsg3NDP_NQOc3aYXLTEvyqv3P0130_assertion wasDerivedFrom befree-20140225 NP498783.RA3AM_NXO9YjQ9EGAjxZsg3NDP_NQOc3aYXLTEvyqv3P0130_provenance.
- NP498783.RA3AM_NXO9YjQ9EGAjxZsg3NDP_NQOc3aYXLTEvyqv3P0130_assertion wasGeneratedBy ECO_0000203 NP498783.RA3AM_NXO9YjQ9EGAjxZsg3NDP_NQOc3aYXLTEvyqv3P0130_provenance.